SECTOR
Sai Life Sciences collaborates with Mabtech
Jan-29-2026

Sai Life Sciences and Mabtech have entered into strategic collaboration that establishes the company’s Boston laboratory as a co-marketed US execution and demonstration hub for the Mabtech EYRA platform.  

Under this collaboration, Mabtech and Sai Life Sciences will jointly deliver advanced immunology assay services - including high-sensitivity multiplex cytokine and phenotyping workflows - powered by the EYRA platform installed at the company’s Boston discovery site. This initiative accelerates access to next-generation immune profiling capabilities for biopharma and biotech companies working in immuno-oncology, vaccines, inflammation, and cellular therapy.

Sai Life Sciences is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization.

  RELATED NEWS >>